Danielle Boyle: The Person I Was and the Person I Became After My ITP Diagnosis
Danielle Boyle, Founder and CEO of ITP Australia and New Zealand, reposted from ITP Australia and New Zealand on LinkedIn:
”Who I was before my diagnosis is not the same person I became during my ITP storm, and not the same person I am today.
Taking the time to understand those changes, and accepting that I will keep evolving, doesn’t just shape me.
It changes how I see everything.”
Quoting ITP Australia and New Zealand‘s post:
”A diagnosis doesn’t just alter a patient’s medical pathway – it often reshapes their identity.
Before diagnosis, many individuals see themselves as capable, active and independent.
After diagnosis, their identity may shift toward caution, uncertainty and hyper‑awareness of symptoms.
Over time, many develop a new sense of self — one that integrates lived experience, self‑advocacy, resilience and a deeper understanding of their own health.
These identity transitions matter.
They influence engagement, communication, adherence, mental health and the patient–clinician relationship.
A question for those working in haematology, chronic illness care or rare disease support:
‘How do you see identity shift show up in your patients, and how do you support them through it?‘
Your insights can help shape more compassionate, patient‑centred care.”

Stay updated with Hemostasis Today.
-
May 29, 2026, 17:23Rita Schwab: Current Clinical Management of Trauma without the Use of Allogenic Blood Products
-
May 29, 2026, 17:22Brian Schiro: Excited to Provide Guideline Based Care at the Aortic Center
-
May 29, 2026, 17:20Martin Widschwendter: How Molecular Detection Tests Could Transform Endometrial Cancer Care
-
May 29, 2026, 17:18Nina Lansbury: Supporting a Period Friendly World With Menstrual Health Research and Education
-
May 29, 2026, 17:16Ipsita Chatterjee: Red is Not Shame, Red is Power, Red is a Woman
-
May 29, 2026, 16:49Abdulrahman Nasiri: The Evolving Role of Romiplostim in SAA
-
May 29, 2026, 16:46Soumen Bhattacharya: UC-II and Immune Modulation in Osteoarthritis
-
May 29, 2026, 16:38Ana Pedrero Gil: Red Blood Cell Transfusion Practice in Spain – High Inappropriateness Despite Low Overall Use
-
May 29, 2026, 15:40Lena Volland: Expanding Holistic Care in Bleeding Disorders Through Pelvic Health Physical Therapy at WFH Congress